Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Troy Cox
AddedFeb 13, 2024
UpdatedMay 31, 2026
Troy Cox

Troy Cox

Board Member, LetsGetChecked

LinkedIn

Troy Cox's Career

LetsGetChecked
LetsGetChecked

New York City, NY, US

Board Member· Board
Biosplice Therapeutics
Biosplice Therapeutics

San Diego, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Troy Cox's Career

LetsGetChecked
LetsGetChecked
Late Stage Private$393M6272015New York City, NY, US
Board Member· Board

Recent news

With government backing, Ireland’s Elkstone closes first VC fund at $108M for early-stage startupsTechCrunch · 2023

Leadership at LetsGetChecked

Nick NaclerioNick NaclerioBoard Member
Peter FoleyPeter FoleyCEO

Similar to LetsGetChecked

Everly WellEverly WellAustin, TX, USHealth Testingest. 2015Everly WellAustin, TX, US · est. 2015

Everly Well, Inc.: Texas-based health testing services for food sensitivity, women's fertility, and thyroid.

Series D · $325M175
Included HealthIncluded HealthSan Francisco, CA, USHealthcare, Virtual Careest. 2011Included HealthSan Francisco, CA, US · est. 2011

Included Health: Combining tech and human touch for personalized virtual and community-based healthcare.

Series E · $344M1.6k
Dr.OnlineDr.OnlineNew York City, NY, USHealthcare, Wellnessest. 2020Dr.OnlineNew York City, NY, US · est. 2020

Dr.Online: Affordable, quality healthcare services and products online for a healthier, happier life.

Pre-Seed · $20k7
PreventlyPreventlyCambridge, MA, USHealth Products, Telemedicineest. 2012PreventlyCambridge, MA, US · est. 2012

Prevently: Your online hub for physician-approved health products, articles, and telemedicine services.

Series A · $2.2M30
Biosplice Therapeutics
Biosplice Therapeutics
Late Stage Private$778M632008San Diego, CA, US
Board Member· Board

Leadership at Biosplice Therapeutics

Osman KibarOsman KibarBoard Member
Cevdet SamikogluCevdet SamikogluBoard Member
Gur RoshwalbGur RoshwalbBoard Member
Mr. Cevdet SamikogluMr. Cevdet SamikogluCEO

Similar to Biosplice Therapeutics

Blade TherapeuticsBlade TherapeuticsSouth San Francisco, CA, USDrug Developmentest. 2013Blade TherapeuticsSouth San Francisco, CA, US · est. 2013

Blade Therapeutics: A US-based biopharmaceutical company specializing in fibrosis treatment and drug development.

Series D · $51.5M28
SpinogenixSpinogenixSan Diego, CA, USTherapeuticsest. 2016SpinogenixSan Diego, CA, US · est. 2016

Spinogenix: Developing transformative therapeutics for synaptic loss and dysfunction.

Pre-Seed · $11.6M8
AmplicoreAmplicoreMason, OH, USPharmaceuticals, Therapeuticsest. 2019AmplicoreMason, OH, US · est. 2019

Amplicore develops regenerative injectable therapeutics for musculoskeletal disorders.

Seed · $4M8
Angiocrine BioscienceAngiocrine BioscienceSan Diego, CA, USGene Therapyest. 2012Angiocrine BioscienceSan Diego, CA, US · est. 2012

San Diego-based Angiocrine Bioscience is a clinical-stage company using gene therapy to regenerate tissues and rejuvenate patients.

Series B · $77.1M36

People Similar to Troy Cox

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · KakaoTomer BerkovitzTomer BerkovitzBoard Member · PrognomiQTom PetroTom PetroBoard Member · UnivestAnthony PhilippakisAnthony PhilippakisBoard Member · Verve TherapeuticsJohn RiceJohn RiceCo-Founder · Triathlon Medical Venture PartnersCraig C TaylorCraig C TaylorCo-Founder · Alloy VenturesParis PanayiotopoulosParis PanayiotopoulosBoard Member · Anthos Therapeutics